DE69902092D1 - Regulierung der ovarianreifung und ovarianfunktion mit dem eipdermalen wachstumsfactor - Google Patents

Regulierung der ovarianreifung und ovarianfunktion mit dem eipdermalen wachstumsfactor

Info

Publication number
DE69902092D1
DE69902092D1 DE69902092T DE69902092T DE69902092D1 DE 69902092 D1 DE69902092 D1 DE 69902092D1 DE 69902092 T DE69902092 T DE 69902092T DE 69902092 T DE69902092 T DE 69902092T DE 69902092 D1 DE69902092 D1 DE 69902092D1
Authority
DE
Germany
Prior art keywords
ovarian
eipdermal
riping
growth factor
regulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69902092T
Other languages
English (en)
Other versions
DE69902092T2 (de
Inventor
H Lee
J Mcglone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas Tech University TTU
Original Assignee
Texas Tech University TTU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas Tech University TTU filed Critical Texas Tech University TTU
Publication of DE69902092D1 publication Critical patent/DE69902092D1/de
Application granted granted Critical
Publication of DE69902092T2 publication Critical patent/DE69902092T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
DE69902092T 1998-04-14 1999-04-14 Regulierung der ovarianreifung und ovarianfunktion mit dem eipdermalen wachstumsfactor Expired - Fee Related DE69902092T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6006098A 1998-04-14 1998-04-14
US09/212,581 US6300311B1 (en) 1998-04-14 1998-12-14 Regulation of vertebrate ovarian maturation and function using growth factors
PCT/US1999/008192 WO1999052544A2 (en) 1998-04-14 1999-04-14 Regulation of ovarian maturation and function using epidermal growth factor

Publications (2)

Publication Number Publication Date
DE69902092D1 true DE69902092D1 (de) 2002-08-14
DE69902092T2 DE69902092T2 (de) 2003-02-27

Family

ID=26739519

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69902092T Expired - Fee Related DE69902092T2 (de) 1998-04-14 1999-04-14 Regulierung der ovarianreifung und ovarianfunktion mit dem eipdermalen wachstumsfactor

Country Status (11)

Country Link
US (1) US6300311B1 (de)
EP (1) EP1071446B1 (de)
JP (1) JP2002511420A (de)
KR (1) KR20010042656A (de)
AU (1) AU3561199A (de)
BR (1) BR9909628A (de)
DE (1) DE69902092T2 (de)
DK (1) DK1071446T3 (de)
ES (1) ES2180295T3 (de)
MX (1) MXPA00010010A (de)
WO (1) WO1999052544A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056858B1 (de) 1998-02-19 2004-12-08 Eastern Virginia Medical School Rekombinantes aktives humänes zona pellucida protein 3 (hzp3)
US7037663B2 (en) 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
WO2003011118A2 (en) 2001-08-02 2003-02-13 Trinity Biomedical Technology Corporation Human zona pellucida proteins and methods of their use in diagnosing male infertility
AU2008321225B2 (en) * 2007-11-13 2013-08-01 Phoenix Biotechnology Inc. Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
CN101932331B (zh) * 2008-01-17 2012-10-24 刘奎 卵泡体外成熟方法
KR20170002086A (ko) 2015-06-29 2017-01-06 주식회사 포워드벤처스 정보 전송 장치 및 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734398A (en) 1983-03-15 1988-03-29 University Of Southern California Follicular regulating protein
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US5010055A (en) 1986-06-24 1991-04-23 The General Hospital Corporation Use of EGF to reverse the contraceptive activity of MIS
DK49987A (da) 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
IL87982A0 (en) 1988-10-10 1989-03-31 Israel Oceanographic & Limnolo Compositions and methods for manipulating ovulation and spawning in fish
US5496720A (en) 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
US5563059A (en) 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5395825A (en) 1993-03-10 1995-03-07 Yale University Fertility regulation with transforming growth factor β
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
JP2000508531A (ja) 1996-04-10 2000-07-11 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 細胞外／上皮増殖因子様タンパク質

Also Published As

Publication number Publication date
WO1999052544A9 (en) 1999-12-09
WO1999052544A3 (en) 2000-01-20
EP1071446B1 (de) 2002-07-10
DK1071446T3 (da) 2002-10-14
KR20010042656A (ko) 2001-05-25
DE69902092T2 (de) 2003-02-27
US6300311B1 (en) 2001-10-09
ES2180295T3 (es) 2003-02-01
EP1071446A2 (de) 2001-01-31
AU3561199A (en) 1999-11-01
JP2002511420A (ja) 2002-04-16
BR9909628A (pt) 2001-10-16
MXPA00010010A (es) 2004-03-10
WO1999052544A2 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
AU6543398A (en) Delay-locked loop with binary-coupled capacitor
GB2332893B (en) Aerofoil profile with variable profile adaptation
DE69814431D1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
DE59507141D1 (de) Verschluss mit variablem schlosseinsatz
GB2332894B (en) Aerofoil profile member with variable profile adaptation
DE69916195D1 (de) Polythioether und ihre Verwendung
DE69910313D1 (de) Photothermographisches Material mit gewünschtem Farbton
DE69806419T2 (de) Harzzusammensetzung und ihre Verwendung
DE69902092T2 (de) Regulierung der ovarianreifung und ovarianfunktion mit dem eipdermalen wachstumsfactor
DE69614401T2 (de) Ausgleichsventil mit variablem querschnitt
DE58904018D1 (de) Enantiomere silane, modifiziertes traegermaterial und dessen verwendung.
DE69714358D1 (de) 9,10-disubstituierte campothecinderivate mit antitumoraktivität
DE69521174D1 (de) Anthrachinonderivate mit antitumorwirkung und ihre verwendung
DE29706735U1 (de) Beleuchtungselement mit veränderlichen Lichteffekten
DE58904019D1 (de) Enantiomere silane, modifiziertes traegermaterial und dessen verwendung.
DE69203699D1 (de) Arylindazolderivate und ihre Verwendung.
DE69714970T2 (de) Hydroismerisierung mit verminderten hydrokracken
DE69732095D1 (de) Ionomerzusammensetzung und ihre verwendung
DE69717540T2 (de) Verstärker mit variabler Verstärkung und grossem Steuerbereich
DE9406586U1 (de) Verschluß mit variablem Schloßeinsatz
ATA242394A (de) Aufschlämmbares material und mit dem material erhaltenes bauelement
DE59308512D1 (de) Cyclohexenonoximether, ihre herstellung und ihre verwendung
DE9319704U1 (de) Heizkörper mit variabler Versorgung und Gestaltung
DE68905998D1 (de) Modulationsart mit linearen phasenspruengen und konstanter umhuellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee